Key facts
- This page summarizes Tom Gwydir Power's Form 4 filing for NEPHROS INC (NEPH).
- 2 reported transactions and 5 derivative rows are listed below.
- Accepted by SEC: 09 Jan 2023, 15:31.
Tom Gwydir Power - 05 Jan 2023 Form 4 Insider Report for NEPHROS INC (NEPH)
- Reporting relationship
- Director
- Issuer ticker
- NEPH
- Reported as of
- 05 Jan 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 09 Jan 2023, 15:31:54 UTC
- Prior SEC filing
- 16 Dec 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Christopher Melsha as attorney-in-fact for Tom Gwydir pursuant to power of attorney previously filed.
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Tom Gwydir Power filed Form 4 for NEPHROS INC (NEPH) on 09 Jan 2023.
Change
- Previous filing in this sequence was filed on 16 Dec 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
NEPH
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +27,613
- Change %
- +177%
- Price
- $0.000000
- Shares after
- 43,226
- Date
- 05 Jan 2023
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
NEPH
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +7,080
- Change %
- Price
- $0.000000
- Shares after
- 7,080
- Date
- 05 Jan 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 7,080
- Exercise price
- $1.07
- Footnotes
- F4
NEPH
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 9,627
- Date
- 05 Jan 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 9,627
- Exercise price
- $5.31
- Footnotes
- F2
NEPH
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 5,568
- Date
- 05 Jan 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- $5,568
- Exercise price
- $8.57
- Footnotes
- F2
NEPH
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 6,850
- Date
- 05 Jan 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- $6,850
- Exercise price
- $8.06
- Footnotes
- F2
NEPH
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 7,062
- Date
- 05 Jan 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 7,062
- Exercise price
- $6.82
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Represents shares of restricted stock granted to the reporting person in lieu of cash fees payable to the reporting person for his service on the Company's Board of Directors for 2022. These shares of restricted stock vest 6 months following the grant date.
Footnote F2
Fully exercisable.
Footnote F3
This option vests as to 2,354 shares on each of 12/14/21, 12/14/22 and 12/14/23.
Footnote F4
Represents options granted to the reporting person for his service on the Company's Board of Directors for 2022. This option vests as to 2,360 shares on each of 1/5/23, 1/5/24 and 1/5/25.